FM
EPIX

Frazier Management’s ESSA Pharma EPIX Stock Holding History

Frazier Management’s Portfolio EPIX Stock Details EPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-543,470
Closed -$7.72M – 12
2021
Q4 		$7.72M Buy
543,470
+185,124
+52% +$2.06M 0.59% 33
2021
Q3 		$2.87M Buy
358,346
+41,730
+13% +$663K 0.23% 36
2021
Q2 		$9.05M Hold
316,616
– – 0.83% 22
2021
Q1 		$9.2M Buy
+316,616
New +$7.36M 0.74% 23

Other funds holding EPIX

BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Frazier Management's EPIX Position: Q1 2022 in Review

Frazier Management sold out of ESSA Pharma (EPIX) in Q1 2022, closing a stake of 543,470 shares — an estimated $7.72M sold.

Frazier Management first reported a position in EPIX in Q1 2021 and held it in 4 quarters. The position peaked at $9.2M in Q1 2021. 70 funds tracked by Wall St. Rank hold EPIX as of Q1 2022.

  • Frazier Management reported no remaining ESSA Pharma position as of Q1 2022 after selling out during the quarter.
  • Frazier Management sold 543,470 ESSA Pharma shares in Q1 2022, an estimated $7.72M.
  • Frazier Management first reported a position in ESSA Pharma in Q1 2021 and held it in 4 quarters.
  • Frazier Management's ESSA Pharma position peaked at $9.2M in Q1 2021.
  • 70 funds tracked by Wall St. Rank held ESSA Pharma as of Q1 2022.

Based on Frazier Management's 13F filing for Q1 2022, filed 13 May 2022.